A detailed history of Jennison Associates LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 149,350 shares of TYRA stock, worth $3.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149,350
Holding current value
$3.49 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$14.45 - $20.22 $2.16 Million - $3.02 Million
149,350 New
149,350 $2.39 Million
Q4 2021

Feb 08, 2022

SELL
$12.23 - $31.35 $5.73 Million - $14.7 Million
-468,750 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$16.91 - $26.0 $7.93 Million - $12.2 Million
468,750 New
468,750 $8.25 Million

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $980M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.